Key result
Ischaemic mitral regurgitation is a dynamic complication of coronary artery disease that worsens prognosis, with optimal management remaining undefined due to a lack of large randomized trials.
This review highlights the complex pathophysiology of ischemic mitral regurgitation and the ongoing challenges in determining the optimal combination of medical, interventional, and surgical therapies.
No takes yet. Share an insight, caveat, or question.
Therapy for ischaemic mitral regurgitation should remain individualized; leaves open optimal strategies pending large randomized trials.
Piérard et al. (2010) conducted a review in Ischaemic mitral regurgitation. Ischaemic mitral regurgitation is a dynamic complication of coronary artery disease that worsens prognosis, with optimal management remaining undefined due to a lack of large randomized trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: